Jennifer leads Ginkgo’s commercial function, responsible for growing the cell engineering business and delivering value for customers. From bringing programs onto the platform to guiding customer success all the way through to commercial scale-up and product delivery, Jennifer and her team bring synthetic biology products to life. Jennifer brings a technical background and experience in large-scale biological manufacturing; prior to Ginkgo, Jennifer spent more than a decade at Merck and Co., where she worked in Vaccine development, Plant management domestically and internationally, and U.S Market commercial roles. Jennifer holds an M.S. in Chemical Engineering from Stanford University and a B.S. in Bioengineering from the University of Arizona.